Other Drug Channels News Roundup, March 2026: Cigna’s 340B Workaround, Merck’s ARPA Surprise, Walgreens’ Automation Bet, Why Rebates Hurt Patients, and a DCI Team Photo Drug ChannelsSpring is here in always-sunny Philadelphia.OtherRead full story pharminent March 31, 2026 (Last updated: March 31, 2026) Drug Channels Spring is here in always-sunny Philadelphia. OtherRead full story Post navigation Previous: Biotech IPOs stayed at slow pace, but grew larger in the first quarter of 2026Next: UCB brings first therapy for rare disease TK2d to EU Related Stories Other ‘Seismic shift’ as obesity overtakes cancer for R&D returns pharminent May 5, 2026 Other 223: An Interview With Dr. Antn Blatnik on the Molecular Mechanisms Driving Neuromuscular Disease pharminent May 4, 2026 Other FDA tests out ‘real-time’ clinical trials; AbbVie closes in on a KRAS biotech pharminent April 29, 2026
